sharecast

{{ storiesRelated.title }}

Broker Tips
26 Oct
synthomer, chemicals
Broker tips: Pearson, Beazley, Synthomer, Renishaw

Pearson rallied on Monday after UBS upgraded its rating on shares of the education publisher to ‘buy’ from ‘neutral’ and lifted the price target to 650. 0p from 545. 0p as it becomes more positive on US higher education.

26 Oct
pearson education
Monday broker round-up

Pearson: UBS upgrades to buy with a target price of 650p.

26 Oct
pearson education
UBS upgrades Pearson on US higher education opportunity

Pearson rallied on Monday after UBS upgraded its rating on shares of the education publisher to ‘buy’ from ‘neutral’ and lifted the price target to 650p from 545p as it becomes more positive on US higher education.

26 Oct
Morgan Stanley downgrades Beazley, cites limited upside

Morgan Stanley downgraded its stance on insurer Beazley to ‘equalweight’ from ‘overweight’ and cut the price target to 350p from 550p as it said the company’s limited financial flexibility will leave the cost of equity at elevated levels and limit the upside.

26 Oct
renishaw
Berenberg raises target price on Renishaw

Analysts at Berenberg raised their target price on engineering company Renishaw from 5,700. 0p to 6,200. 0p on Monday, stating the firm appeared to be "poised for a recovery".

26 Oct
standardchartered logo (2)
JP Morgan sees increasing chances of capital returns from UK banks in 2021

"We believe it’s hard to overstate the importance of [a successful Brexit deal] (despite lower economic impact) for UK bank share prices as well as potential capital return," analysts at JP Morgan said.

26 Oct
barclays-transfere-a-paris-des-postes-dans-les-derives
Deutsche Bank says Barclays' diversified income stream 'underappreciated'

Analysts at Deutsche Bank reiterated their 'buy' stance for shares of Barclays, arguing that the merits of its diversified income streams was going underappreciated.

26 Oct
synthomer, chemicals
JPMorgan upgrades Synthomer to 'overweight'

JPMorgan Cazenove upgraded its stance on Synthomer on Monday to ‘overweight’ from ‘neutral’ and hiked the price target to 450p from 242p as it highlighted the company’s exposure to the gloves market and potential benefit from the Covid-19 pandemic.